Trial Profile
Randomised Placebo Controlled Trial of a Parenteral Modified Cobratoxin in Adrenomyeloneuropathy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2019
Price :
$35
*
At a glance
- Drugs RPI 78M (Primary)
- Indications Adrenomyeloneuropathy
- Focus Registrational; Therapeutic Use
- Sponsors Receptopharm
- 22 Jun 2018 New trial record